Malaria,Mefloquine and Oil-Workers

Abstract

Get full access to this article

View all access options for this article.

References

National Statistics Website (www.statisties.gov.uk).

Taylor

, Smith

, Khaund

, Basu

Malaria in the North-East of Scotland. A review of 31 cases (1974-1978). Scot Med J; 24: 296.

Nathwani

, Badial

, Khaund

, Douglas

, Smith

CC.

Malaria in Aberdeen: an audit of 110 patients admitted between 1980-91. Scot MedJ 1992; 37: 106–110.

Kennedy

, Walker

Malaria at the Millenium. Scot Med J 1997; 42: 03.

Berger

Science commentary. Protection against malaria. Br Med J 1998; 317: 1508.

Wilkins

, Welsby

PD.

Epidemiology and awareness of malaria in the Lothians. Scot Med J 1997; 42: 10–12.

Nathwani

, Spiteri

Information about anti-malarial chemoprophylaxis in hospitalised patients - is it adequate?

Scot Med J 1997; 42: 13–15.

Reid

AJC

, Whitty

, Ayles

HM.

Malaria at Christmas: risks of prophylaxis versus risks of malaria. Br Med J 1998; 317: 1506–814.

Croft

Malaria: prevention in travellers. Br Med J 2000; 321: 154–60.

10.

Steffen

, Fuchs

, Schildknech

TJ.

Mefloquine compared to other chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299–303.

11.

Lobel

, Miani

, Eng

, Bernard

, Hightower

, Campbell

CC.

Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848–51.

12.

Blaze

, Smith

Malaria imported into the United Kingdom - 1997. Travel Wise 1998; 03: 05.

13.

Phillips-Howard

, Radalowicz

, Mitchell

, Bradley

DJ.

Risk of malaria in British residents returning from malarious areas. Br Med J 1990; 300: 499–503.

14.

Barrett

, Emmins

, Clarke

, Bradley

DJ.

Comparison of adverse events associated with use of mefloquine and combination chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. Br Med J 1996; 313: 525–8.

15.

Schlagenhauf

Mefloquine for malaria prophylaxis 1992-1998: a review. J Travel Med 1999; 6: 122–33.

16.

Davis

TME

, Lawrence

, Kaye-Eddie

, Hewitt

, Hislop

, Batty

KT.

Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996; 42: 415–21.

17.

Weiss

, Aggrey

, Johnson

, Koech

, Hoffinan

SL.

Daily primaquine is effective for prophylaxis against falciparum, malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. JID 1995; 171: 1569–75.

18.

Fryauff

, Baird

, Basri

, Sumwinata

, Purnomo , Richie

, Orht

, Mouzin

, Church

, Richards

, Subianto

, Sandjaja

, Wignall

, Hoffman

SL.

Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995; 346: 1190–1193.

19.

Lell

, Luckner

, Ndjave

, Scott

, Kremsner

PG.

Randomised placebo-controlled study of atovoquone plus proguanil for malaria prophylaxis in children. Lancet 1998; 351: 709–13.

20.

Brueckner

, Coster

, Wesche

, Shmuklarsky

, Schuster

BG.

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinolone antimalarial. Antimicrob Agents Chemother 1998; 42: 1293–94.

21.

Walsh

, Looareesuwan

, Wilairatana

, Heppner

, Tang

, Brewer

, Chokejindachai

, Viriyavejakul

, Kyle

, Milhous

, Schuster

, Horton

, Braitman

, Brueckner

RP.

Randomized dose-ranging study of safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis 1999; 180: 1282–7.

22.

Malaria in Mexico and South Africa. SCIEH Weekly Report 2000; 34: Nos. 2000/10; 57.